Last reviewed · How we verify

NCT07369908

The Effects of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Anxiety Responses and Emotional Regulation

Recruiting now NA Last updated 27 January 2026
What this trial tests

NA trial testing taVNS on tragus of subjects with high trait anxiety in Healthy Male and Female Volunteers in 140 participants. Currently enrolling.

Timeline
9 October 2025
Primary endpoint
16 March 2026
16 April 2026

Quick facts

Lead sponsorUniversity of Electronic Science and Technology of China
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposebasic science
Enrollment140
Start date9 October 2025
Primary completion16 March 2026
Estimated completion16 April 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

University of Electronic Science and Technology of China

Who can join

Adults 18 to 30, any sex, with Healthy Male and Female Volunteers. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of this study is to investigate whether transcutaneous auricular vagus nerve stimulation (taVNS) can reduce anxiety and have an effect on emotional regulations

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other University of Electronic Science and Technology of China trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07369908.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing